CGTLive®’s Weekly Rewind – August 9, 2024

News
Article

Review top news and interview highlights from the week ending August 9, 2024.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind

Welcome to CGTLive®’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.

1. Indapta to Evaluate g-NK Therapy in Trial for Progressive Multiple Sclerosis

The trial evaluating the safety and tolerability of IDP-023 will be led by Stanford and UCSF.

2. Joshua M. Hare, MD, on Working to Address Unmet Needs in Alzheimer Disease With Lomecel-B Cell Therapy

The cofounder and chief science officer of Longeveron discussed working to show potential benefits in a follow-up phase 3 trial.

3. FDA Modifies CAR-T Risk Strategies to Lower Healthcare Burden

A recent study also recommended a shorter, more flexible monitoring period post-CAR–T therapy.

4. David Dimmock, MBBS, on a Promising Case Study of Ultra-Rare, AI-Guided, ASO Development

The chief medical officer at Creyon Bio discussed findings from a treated patient with a TNP02 missense mutation.

5. Pivotal Bria-IMT Trial Hopes to Support BLA for Advanced Metastatic Breast Cancer

BriaCell initiated the pivotal phase 3 BRIA-ABC trial in October 2023.

Newsletter

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Recent Videos
Jeffrey Chamberlain, PhD
Tami John, MD
Tami John, MD
Tami John, MD
Matthew Ku, MBBS, FRACP, RACP, FRCPA/RCPA, PhD, an associate professor and the lymphoma stream lead at St Vincent’s Hospital
Saurabh Dahiya, MD, FACP, an associate professor of medicine at Stanford University School of Medicine; as well as clinical director of Cancer Cell Therapy in the Division of Blood and Marrow Transplantation and Cell Therapy at Stanford Medicine
Shahzad Raza, MD, a hematologist/oncologist at the Cleveland Clinic
Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
Shahzad Raza, MD, a hematologist/oncologist at the Cleveland Clinic
Laura Aguilar MD, PhD, the chief medical officer of Diakonos Oncology
© 2025 MJH Life Sciences

All rights reserved.